Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Radiation Oncology (London, England)|September 24, 2009
Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleedingMichael Pinkawa, Marc D Piroth, Karin Fischedick, et al.
International Journal of Environmental Research and Public Health|September 28, 2021
Genome of Helicobacter pylori and Serotype of HPV Detected in Oropharyngeal and Laryngeal Cancer and Chronic Inflammation PatientsJaromír Astl, Richard Holy, Eva Maute, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 27, 2011
Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancerMichael Pinkawa, Marc D Piroth, Richard Holy, et al.
Journal of Applied Biomedicine|September 25, 2023
The importance of preoperative and perioperative Narrow Band Imaging endoscopy in the diagnosis of pre-tumor and tumor lesions of the larynxTomas Filipovsky, David Kalfert, Eva Lukavcova, et al.
International Journal of Radiation Oncology, Biology, Physics|September 14, 2010
Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparisonMichael Pinkawa, Marc D Piroth, Richard Holy, et al.
Radiation Oncology (London, England)|April 10, 2010
Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life studyMichael Pinkawa, Richard Holy, Marc D Piroth, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 10, 2009
Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancerMichael Pinkawa, Marc D Piroth, Karin Fischedick, et al.
Brachytherapy|September 8, 2009
Rectal morbidity after permanent interstitial brachytherapy for prostate cancer--impact of day 1 vs. day 30 computed tomography-based postimplant dosimetryMichael Pinkawa, Marc D Piroth, Richard Holy, et al.
Radiation Oncology (London, England)|December 12, 2012
Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapyMichael Pinkawa, Marc D Piroth, Richard Holy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2007
Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysisMichael Pinkawa, Karin Fischedick, Branka Asadpour, et al.
Pageof 6